Yiyoung Kwon Selected Research

Crohn Disease (Crohn's Disease)

1/2023	Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response.
1/2023	Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn's disease.
11/2022	Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission.
1/2022	Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease.
1/2020	The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiyoung Kwon Research Topics

Disease

5	Crohn Disease (Crohn's Disease) 01/2023 - 01/2020
4	Pediatric Crohn's disease 09/2023 - 01/2022
2	Necrosis 09/2023 - 01/2023
2	Ulcerative Colitis 05/2023 - 07/2022
2	Inflammation (Inflammations) 09/2022 - 01/2022
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2021
1	Pyoderma Gangrenosum 05/2023
1	Biliary Atresia 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2022
1	Body Weight (Weight, Body) 01/2021
1	Lymphangiectasis 01/2021
1	Obesity 01/2021
1	Neoplasms (Cancer) 11/2019
1	Infections 11/2019
1	Viremia 11/2019

Drug/Important Bio-Agent (IBA)

6	Infliximab (Remicade)FDA Link 09/2023 - 07/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	vedolizumabIBA 05/2023 - 09/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 01/2022
1	Immunologic Factors (Immunomodulators)IBA 09/2023
1	Methotrexate (Mexate)FDA LinkGeneric 09/2023
1	AntibodiesIBA 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 11/2022
1	CytokinesIBA 09/2022
1	AlbuminsIBA 01/2022
1	GlobulinsIBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	EnzymesIBA 01/2021
1	LipidsIBA 01/2021
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
1	Biological Therapy 05/2023
1	Liver Transplantation 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 11/2019
1	Stem Cell Transplantation 11/2019
1	Kidney Transplantation 11/2019